Home » Press Releases » In Response to Shareholder Pressure, Pharma Companies Begin to Acknowledge Drug Pricing Controversies as a Business Risk In Response to Shareholder Pressure, Pharma Companies Begin to Acknowledge Drug Pricing Controversies as a Business Risk 20 June 2019 pr_2019_drug_pricing_campaign_6-18-19_final.pdf Share
